Loading
Latest filing published 17 Feb 2026 for Macrogenics INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Thomas Spitznagel in Macrogenics Inc, where the filings describe the role as senior executive. In total, 24 filings cover trades dated from 6 February 2019 to 15 February 2026.
On the market, this insider has only sold: 6 sales, €808k in total. Other entries cover 6 share grants and 12 option exercises.
Most recently, on 17 February 2026, the filings show a share grant worth €7,953 in Macrogenics Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations